OTCMKTS:EMMBF

Emblem Stock Forecast, Price & News

$1.40
+0.02 (+1.45 %)
(As of 03/18/2019)
Add
Compare
Today's Range
$1.36
Now: $1.40
$1.45
50-Day Range
$1.40
MA: $1.40
$1.40
52-Week Range
$0.60
Now: $1.40
$1.63
Volume156,200 shs
Average Volume280,719 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Emblem Corp. produces, distributes, and sells medical cannabis and cannabis derivatives in Canada. The company also operates medical cannabis education centers to provide education services for making informed decisions about medical cannabis treatment options to physicians and patients. In addition, it provides various accessories. Emblem Corp. has a strategic partnership with GreenSpace Brands to develop and commercialize cannabidiol infused health and beauty products. The company is headquartered in Toronto, Canada. As of March 14, 2019, Emblem Corp. operates as a subsidiary of Aleafia Health Inc.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:EMMBF
CUSIPN/A
CIKN/A
Phone(416) 962-3300
Employees74
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

Emblem Cannabis Corporation - Benzinga
December 15, 2020 |  benzinga.com
Variety: Acrostic - The New York Times
December 5, 2020 |  nytimes.com
(4 - CNN
November 4, 2020 |  cnn.com
See More Headlines

MarketRank

Overall MarketRank

0.60 out of 5 stars

Medical Sector

1376th out of 2,016 stocks

Biotechnology Industry

56th out of 144 stocks

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$1.40
+0.02 (+1.45 %)
(As of 03/18/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive EMMBF News and Ratings via Email

Sign-up to receive the latest news and ratings for EMMBF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Emblem (OTCMKTS:EMMBF) Frequently Asked Questions

What stocks does MarketBeat like better than Emblem?

Wall Street analysts have given Emblem a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Emblem wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Emblem's stock price been impacted by COVID-19?

Emblem's stock was trading at $1.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EMMBF stock has increased by 0.0% and is now trading at $1.40.
View which stocks have been most impacted by COVID-19
.

Who are Emblem's key executives?

Emblem's management team includes the following people:
  • Mr. Nicholas Dean, CEO, Pres & Director
  • Mr. Harvey Allan Shapiro, VP (Age 74)
  • Mr. Maxim Zavet, VP (Age 39)
  • Mr. Gordon Howard Fox, Advisor
  • Mr. Alexander Stojanovic, Chief Financial Officer

Who are some of Emblem's key competitors?

What is Emblem's stock symbol?

Emblem trades on the OTCMKTS under the ticker symbol "EMMBF."

How do I buy shares of Emblem?

Shares of EMMBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Emblem's stock price today?

One share of EMMBF stock can currently be purchased for approximately $1.40.

How many employees does Emblem have?

Emblem employs 74 workers across the globe.

What is Emblem's official website?

The official website for Emblem is emblemcorp.com.

How can I contact Emblem?

The company can be reached via phone at (416) 962-3300.


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.